Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving …

H Watanabe, T Domei, T Morimoto, M Natsuaki… - Jama, 2019 - jamanetwork.com
Importance Very short mandatory dual antiplatelet therapy (DAPT) after percutaneous
coronary intervention (PCI) with a drug-eluting stent may be an attractive option. Objective …

Comparison of clopidogrel monotherapy after 1 to 2 months of dual antiplatelet therapy with 12 months of dual antiplatelet therapy in patients with acute coronary …

H Watanabe, T Morimoto, M Natsuaki… - JAMA …, 2022 - jamanetwork.com
Importance Clopidogrel monotherapy after short dual antiplatelet therapy (DAPT) after
percutaneous coronary intervention (PCI) has not yet been fully investigated in patients with …

Late restenosis after paclitaxel-coated balloon angioplasty occurs in patients with drug-eluting stent restenosis

S Habara, K Kadota, T Shimada, M Ohya… - Journal of the American …, 2015 - jacc.org
Background: There are currently inadequate data on whether “late restenosis” occurs after
paclitaxel-coated balloon (PCB) angioplasty for in-stent restenosis (ISR) lesions. Objectives …

Risk factors and long-term clinical outcomes of second-generation drug-eluting Stent thrombosis: Insights from the REAL-ST registry

S Kuramitsu, M Ohya, T Shinozaki, H Otake… - Circulation …, 2019 - Am Heart Assoc
Background: The risk factors and long-term clinical outcomes of patients with definite stent
thrombosis (ST) after second-generation drug-eluting stent (DES) implantation have not yet …

Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial

H Watanabe, T Domei, T Morimoto, M Natsuaki… - Cardiovascular …, 2021 - Springer
Previously we briefly reported the effect of 1-month dual antiplatelet therapy (DAPT) for
patients with high bleeding risk (HBR) receiving percutaneous coronary intervention (PCI) in …

Severe aortic stenosis in dialysis patients

Y Kawase, T Taniguchi, T Morimoto… - Journal of the …, 2017 - Am Heart Assoc
Background Characteristics and prognosis of hemodialysis patients with severe aortic
stenosis have not yet been well defined. Methods and Results The CURRENT AS …

Very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial

H Watanabe, T Domei, T Morimoto, M Natsuaki… - Circulation, 2019 - Am Heart Assoc
CORRESPONDENCE than those in the non-HBR group. High-risk features of stent-driven
recurrent ischemia from the 2017 European Society of Cardiology focused update on DAPT …

Very short dual antiplatelet therapy after drug-eluting stent implantation in patients who underwent complex percutaneous coronary intervention: insight from the …

K Yamamoto, H Watanabe, T Morimoto… - Circulation …, 2021 - Am Heart Assoc
Background: Safety and efficacy of clopidogrel monotherapy after very short dual antiplatelet
therapy (DAPT) is uncertain in patients undergoing complex percutaneous coronary …

Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent …

T Tada, K Kadota, S Hosogi, K Miyake… - European Heart …, 2015 - academic.oup.com
Aims Morphological assessment of neointimal tissue using optical coherence tomography
(OCT) is important for clarifying the pathophysiology of in-stent restenosis (ISR) lesions. The …

Target lesion revascularization after intravascular ultrasound-guided percutaneous coronary intervention

K Yamamoto, H Shiomi, T Morimoto… - Circulation …, 2023 - Am Heart Assoc
Background: Several stent expansion criteria derived from the intravascular ultrasound
(IVUS) evaluation have been proposed to predict future clinical outcomes, but optimal stent …